Abbvie Inc said on Thursday it settled all patent disputes with Novartis AG, granting it a non-exclusive license to manufacture and sell a copycat version of blockbuster drug, Humira.
Source:: Reuters – Business News
Newswire
- [ June 12, 2025 ] Hoth Therapeutics (NASDAQ: HOTH) Secures Japanese Patent for Breakthrough HT-KIT Platform Targeting Mast Cell Diseases Healthcare
- [ June 11, 2025 ] Is this $1.25 stock the Next Billion Dollar Biotech ? NEXT SUPER STOCK Hoth Therapeutics (NASDAQ: HOTH) CEO Interview
- [ June 11, 2025 ] Hoth Therapeutics (NASDAQ: HOTH) Launches Expanded Access Initiative for HT-001, Offering Critical Relief to Cancer Patients Facing Severe Skin Toxicities Healthcare
- [ June 11, 2025 ] Lottery.com (NASDAQ: LTRY) Increases Ownership Stake in Nook Holdings, UAE-Based Sports Incubator Lottery.com Inc. Wed, June 11, 2025 at 4:00 AM PDT 4 min read In This Article: Newsmakers
- [ June 10, 2025 ] BigBear.ai (NYSE: BBAI) and Hardy Dynamics Collaborate to Advance AI Orchestration for U.S. Army Drone Swarm Operations in Project Linchpin Newsmakers
- [ June 5, 2025 ] Hoth Therapeutics (NASDAQ: HOTH) to Spotlight HT-001 in Investor-Focused KOL Event Addressing Breakthrough Combating Cancer Treatment Skin Toxicities Newsmakers
- [ June 4, 2025 ] Core Gaming (NASDAQ: SYTA) Partners with Experienced Mobile App Studio to Advance AI-Driven Tools Strategy Newsmakers
- [ May 29, 2025 ] Snow Lake (NASDAQ: LITM) and Exodys Energy Collaborate to Support the Formation of a New Nuclear Reactor Development and Deployment Company Newsmakers
- [ May 29, 2025 ] Lottery.com Inc. (NASDAQ: LTRY) Enters New Era as Turnaround Completes and Strategic Acquisitions Accelerate Newsmakers
- [ May 23, 2025 ] Next Super Stock Lottery.com (NASDAQ: LTRY) +10X Upside Potential Building Top Online Brands CEO Interview
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.